Medicover AB (publ) (STO:MCOV.B)
Sweden · Delayed Price · Currency is SEK 281.00
-2.50 (-0.88%)
Nov 2, 2026, 5:24 PM CET
Medicover AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 42,705 | 33,291 | 28,827 | 22,463 | 20,830 | 55,247 | |
Market Cap Growth | 9.00% | 15.49% | 28.33% | 7.84% | -62.30% | 127.10% |
Enterprise Value | 58,044 | 48,269 | 41,219 | 33,348 | 30,044 | 59,960 |
Last Close Price | 283.50 | 218.22 | 188.67 | 146.21 | 134.98 | 354.71 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 45.22 | 39.69 | 150.65 | 114.82 | 158.46 | 52.78 |
Forward PE | 35.00 | 33.19 | 53.09 | 88.18 | 54.62 | 60.38 |
PS Ratio | 1.58 | 1.29 | 1.20 | 1.16 | 1.24 | 3.90 |
PB Ratio | 7.03 | 5.65 | 5.14 | 3.83 | 3.68 | 9.56 |
P/TBV Ratio | - | - | - | - | - | 66.91 |
P/FCF Ratio | 20.89 | 16.57 | 18.02 | 21.38 | 63.17 | 46.92 |
P/OCF Ratio | 11.27 | 8.95 | 9.61 | 9.86 | 10.99 | 24.79 |
PEG Ratio | 0.84 | 0.47 | 0.86 | 2.48 | 2.48 | 2.48 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.14 | 1.88 | 1.72 | 1.72 | 1.79 | 4.23 |
EV/EBITDA Ratio | 13.91 | 17.30 | 19.18 | 19.19 | 17.66 | 26.43 |
EV/EBIT Ratio | 29.79 | 28.46 | 40.15 | 48.47 | 39.26 | 35.86 |
EV/FCF Ratio | 28.32 | 24.03 | 25.77 | 31.75 | 91.11 | 50.92 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.64 | 2.64 | 2.53 | 1.90 | 1.85 | 1.36 |
Debt / EBITDA Ratio | 3.85 | 4.07 | 4.54 | 4.32 | 4.30 | 2.86 |
Debt / FCF Ratio | 7.85 | 7.76 | 8.88 | 10.62 | 31.76 | 6.67 |
Net Debt / Equity Ratio | 2.48 | 2.49 | 2.36 | 1.78 | 1.75 | 0.87 |
Net Debt / EBITDA Ratio | 4.90 | 5.25 | 6.16 | 6.03 | 5.83 | 2.20 |
Net Debt / FCF Ratio | 7.35 | 7.30 | 8.28 | 9.97 | 30.10 | 4.25 |
Asset Turnover | 1.04 | 1.04 | 1.03 | 0.93 | 0.86 | 0.99 |
Inventory Turnover | 30.11 | 26.81 | 25.58 | 23.59 | 17.97 | 15.72 |
Quick Ratio | 0.48 | 0.58 | 0.64 | 0.62 | 0.74 | 1.45 |
Current Ratio | 0.55 | 0.70 | 0.79 | 0.76 | 0.94 | 1.70 |
Return on Equity (ROE) | 15.49% | 14.06% | 2.87% | 3.55% | 2.56% | 20.39% |
Return on Assets (ROA) | 4.66% | 4.30% | 2.74% | 2.05% | 2.44% | 7.27% |
Return on Invested Capital (ROIC) | 6.83% | 6.53% | 4.18% | 3.36% | 3.94% | 13.30% |
Return on Capital Employed (ROCE) | 12.00% | 9.10% | 5.70% | 4.30% | 4.70% | 12.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.21% | 2.52% | 0.66% | 0.87% | 0.63% | 1.90% |
FCF Yield | 4.79% | 6.03% | 5.55% | 4.68% | 1.58% | 2.13% |
Dividend Yield | 0.79% | 0.98% | 0.90% | 0.89% | 0.96% | 0.33% |
Payout Ratio | 35.57% | 29.03% | 107.78% | 101.70% | 150.85% | 10.22% |
Buyback Yield / Dilution | -0.61% | -0.52% | -0.36% | -0.47% | -0.41% | -4.66% |
Total Shareholder Return | 0.18% | 0.46% | 0.53% | 0.42% | 0.55% | -4.33% |